These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9110352)

  • 1. Difference in the three-dimensional structure of the sinusoids between hepatocellular carcinoma and cirrhotic liver.
    Shimizu H; Suda K; Yokoyama T
    Pathol Int; 1996 Dec; 46(12):992-6. PubMed ID: 9110352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-dimensional structural changes of hepatic sinusoids in cirrhosis providing an increase in vascular resistance of portal hypertension.
    Shimizu H; Yokoyama T
    Acta Pathol Jpn; 1993 Nov; 43(11):625-34. PubMed ID: 8310823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-D index as a measure for estimating the complexity degree of 3-D sinusoidal structures in the normal and cirrhotic liver and in hepatocellular carcinoma.
    Shimizu H; Suda K
    Anal Quant Cytol Histol; 1998 Dec; 20(6):526-8. PubMed ID: 9870106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoreactivity of sinusoids in hepatocellular carcinoma. An immunohistochemical study using lectin UEA-1 and antibodies against endothelial markers, including CD34.
    Ruck P; Xiao JC; Kaiserling E
    Arch Pathol Lab Med; 1995 Feb; 119(2):173-8. PubMed ID: 7531428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topological difference in the three-dimensional sinusoid structure between normal human liver and hepatocellular carcinoma.
    Shimizu H; Mimoto K; Yokoyama T
    Microvasc Res; 1991 Nov; 42(3):280-7. PubMed ID: 1664034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase-contrast CT: Qualitative and Quantitative Evaluation of Capillarized Sinusoids and Trabecular Structure in Human Hepatocellular Carcinoma Tissues.
    Jian J; Zhang W; Yang H; Zhao X; Xuan R; Li D; Hu C
    Acad Radiol; 2017 Jan; 24(1):67-75. PubMed ID: 27818006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is mallory body formation a preneoplastic change? A study of 181 cases of liver bearing hepatocellular carcinoma and 82 cases of cirrhosis.
    Nakanuma Y; Ohta G
    Cancer; 1985 May; 55(10):2400-4. PubMed ID: 2985233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple occurrence of borderline hepatocellular nodules in human cirrhotic livers: possible multicentric origin of hepatocellular carcinoma.
    Terada T; Nakanuma Y
    Virchows Arch; 1995; 427(4):379-83. PubMed ID: 8548122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver cell dysplasia in normal, cirrhotic, and hepatocellular carcinoma patients.
    Cohen C; Berson SD
    Cancer; 1986 Apr; 57(8):1535-8. PubMed ID: 3004693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathological and morphometric analysis of atypical adenomatous hyperplasia of human cirrhotic livers.
    Terada T; Ueda K; Nakanuma Y
    Virchows Arch A Pathol Anat Histopathol; 1993; 422(5):381-8. PubMed ID: 8391735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Facing the enigma of the vascular network in hepatocellular carcinomas in cirrhotic and non-cirrhotic livers.
    Vasuri F; Fittipaldi S; Giunchi F; Monica M; Ravaioli M; Degiovanni A; Bonora S; Golfieri R; Bolondi L; Grigioni WF; Pasquinelli G; D'Errico-Grigioni A
    J Clin Pathol; 2016 Feb; 69(2):102-8. PubMed ID: 26243063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A clinicopathologic study of adenomatous hyperplasia of the liver in 209 consecutive cirrhotic livers examined by autopsy.
    Terada T; Terasaki S; Nakanuma Y
    Cancer; 1993 Sep; 72(5):1551-6. PubMed ID: 8394196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The vascular profile of regenerative and dysplastic nodules of the cirrhotic liver: implications for diagnosis and classification.
    Roncalli M; Roz E; Coggi G; Di Rocco MG; Bossi P; Minola E; Gambacorta M; Borzio M
    Hepatology; 1999 Nov; 30(5):1174-8. PubMed ID: 10534338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sinusoidal capillarization of human hepatocellular carcinoma: possible promotion by fibroblast growth factor.
    Motoo Y; Sawabu N; Yamaguchi Y; Terada T; Nakanuma Y
    Oncology; 1993; 50(4):270-4. PubMed ID: 8388557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis.
    Mohamad B; Shah V; Onyshchenko M; Elshamy M; Aucejo F; Lopez R; Hanouneh IA; Alhaddad R; Alkhouri N
    Hepatol Int; 2016 Jul; 10(4):632-9. PubMed ID: 26558795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of glypican 3 enriches hepatocellular carcinoma development-related genes and associates with carcinogenesis in cirrhotic livers.
    Liu X; Wang SK; Zhang K; Zhang H; Pan Q; Liu Z; Pan H; Xue L; Yen Y; Chu PG
    Carcinogenesis; 2015 Feb; 36(2):232-42. PubMed ID: 25542894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of small (< or = 20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liver.
    Holland AE; Hecht EM; Hahn WY; Kim DC; Babb JS; Lee VS; West AB; Krinsky GA
    Radiology; 2005 Dec; 237(3):938-44. PubMed ID: 16306035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA synthesis activities of hepatocytes from noncancerous cirrhotic tissue and of hepatocellular carcinoma (HCC) cells from cancerous tissue can predict the survival of hepatectomized patients with HCC.
    Tarao K; Ohkawa S; Shimizu A; Harada M; Nakamura Y; Okamoto N; Ito Y; Tamai S; Iimori K; Sugimasa Y
    Cancer; 1993 Jun; 71(12):3859-63. PubMed ID: 8389652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular carcinoma: incidental finding in cirrhotic explanted livers.
    Caroli-Bottino A; Nascimento CM; Basto S; Ribeiro J; Silveira V; Carvalho AM; Castro PN; Villela-Nogueiro CA; Pannain VL
    Transplant Proc; 2005; 37(6):2791-2. PubMed ID: 16182811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver angiogenesis as a risk factor for hepatocellular carcinoma development in hepatitis C virus cirrhotic patients.
    Mazzanti R; Messerini L; Comin CE; Fedeli L; Ganne-Carrie N; Beaugrand M
    World J Gastroenterol; 2007 Oct; 13(37):5009-14. PubMed ID: 17854145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.